Long-term success of ahmed glaucoma valve in refractory glaucoma
Long-term success of ahmed glaucoma valve in refractory glaucoma作者机构：Department of OphthalmologyDokuz Eylul UniversityIzmirTurkey
出 版 物：《International Journal of Ophthalmology(English edition)》 (国际眼科杂志（英文版）)
年 卷 期：2012年第5卷第1期
页 面：108-112页
核心收录：
学科分类：1002[医学-临床医学] 100212[医学-眼科学] 10[医学]
主 题：Ahmed glaucoma valve encapsulated cyst intraocular pressure refractory glaucoma
摘 要：AIM:To evaluate the long-term results and complications of ahmed glaucoma valve (AGV) implantation in refractory glaucoma.· METHODS:A retrospective review of 13 patients (13 eyes) with refractory glaucoma who underwent AGV implantation and had a minimum follow-up of 18 months was *** patients underwent a complete ophthalmologic examination and intraocular pressure (IOP) measurement before surgery and at 1 month,3 months,6 months,1 year after surgery and yearly *** and the number of antiglaucoma medications needed were recorded.· RESULTS:Mean age was 27.3±16.0 *** eyes (100%) had at least one prior incisional *** follow-up was 61.3±30.8 *** was reduced from a mean of 35.0±7.0mmHg to 18.2±7.9mmHg at 12 months and to 17.0±4.1mmHg at 96 months (P 0.05) with a lower number of medications from baseline,76.9% patients required additional procedures to achieve the success criteria set by previously published *** most common complications were encapculated cyst formation in eight eyes (61.5%) and tube exposure in four eyes (30.8%).· CONCLUSION:Encapsulated cyst formation was the most common complication which hindered succesful IOP control after AGV implant insertion for refractory *** cyst excision with anti-fibrotic agents,successful IOP reduction was not achieved in 76.9% of the patients without antiglaucoma medication.
维普期刊数据库